14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:CTIC
Delisted

CTI BioPharma Stock Predictions

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$9.09
+0 (+0%)
At Close: Sep 22, 2023
Forecast Insider Trading Signals Historical Prices Predictions News Profile
Currently predicting for Mon, 6 May 2024

CTIC Predictions History

7 years ago
 JS predicted that CTIC for 2016-12-07 is going $0.531 (-89.38%)

7 years ago
 Abdu predicted that CTIC for 2016-12-07 is going $0.520 (-90.55%)

7 years ago
 JS predicted that CTIC for 2016-05-10 is going $0.430 (-90.23%)

Click to get the best stock tips daily for free!

About CTI BioPharma Corp.

CTI BioPharma CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients with myelofibrosis. It has license and collaboration agreement with Teva Pharmaceutical Industries Ltd.;... CTIC Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT